Cost-utility analysis of pacemakers for the treatment of vasovagal syncope

Authors
Mitton, CR Rose, MS Koshman, ML Sheldon, RS
Citation
Cr. Mitton et al., Cost-utility analysis of pacemakers for the treatment of vasovagal syncope, AM J CARD, 84(11), 1999, pp. 1356
Citations number
16
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF CARDIOLOGY
ISSN journal
00029149 → ACNP
Volume
84
Issue
11
Year of publication
1999
Database
ISI
SICI code
0002-9149(199912)84:11<1356:CAOPFT>2.0.ZU;2-5
Abstract
Dual-chamber pacing is a promising treatment for patients with very frequen t vasovagal syncope, but its cost utility is unknown. We report that the in cremental cost per quality-adjusted life-year gained is $13,159 Canadian do llars (about $8,600 US dollars), and therefore this pacemaker therapy for v asovagal syncope has a favorable cost-utility ratio.